SIC 8071 – Medical Laboratories
| Valuation | |
|---|---|
| Market Cap ($M) | 4,609.82 |
| Enterprise Value ($M) | 5,063.36 |
| Book Value ($M) | -60.10 |
| Book Value / Share | -0.49 |
| Price / Book | -76.71 |
| NCAV ($M) | -372.11 |
| NCAV / Share | -3.01 |
| Price / NCAV | -12.39 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.40 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | -3.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.85 |
| Current Ratio | 6.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,226.71 |
| Assets | 1,538.73 |
| Liabilities | 1,598.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Cadian Capital Management, Lp | 5.70 | ||
| 13G | Wellington Management Group Llp | 8.23 | ||
| 13G | Deep Track Capital, LP | 5.35 | -6.00 | |
| 13G/A | Baillie Gifford & Co | 4.98 | -1.38 | |
| 13G/A | Vanguard Group Inc | 9.18 | 23.12 | |
| 13G/A | Fmr Llc | 4.50 | -40.48 | |
| 13G/A | Capital International Investors | 3.40 | -49.06 | |
| 13G/A | BlackRock, Inc. | 8.90 | 97.11 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 226,093 | 1,001,343 | 22.58 | |
| 280,737 | 922,346 | 30.44 | |
| 337,972 | 1,350,003 | 25.03 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FTRE – Fortrea Holdings Inc. | NTRA – Natera, Inc. |
Financial data and stock pages provided by
Fintel.io